Alumis (ALMS) Other financing activities (2023 - 2025)
Alumis (ALMS) posted quarterly Other financing activities of $829000.0 for Q4 2025, down 99.46% year-over-year from $153.3 million in Q4 2024, and down 99.46% quarter-over-quarter from $153.3 million in Q4 2024.
Analysis
Alumis (ALMS) Other financing activities (2023 - 2025) Analysis & Trends
Alumis (ALMS) has reported Other financing activities for 3 consecutive years, with $829000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other financing activities fell 99.46% year-over-year to $829000.0; the TTM figure through Dec 2025 stood at $193.6 million (changed 0.15% YoY), while the FY2025 annual figure was $1.6 million, down 99.17% from the prior year.
- Other financing activities fell to $829000.0 in Q4 2025 per ALMS's latest filing, from $153.3 million in the prior quarter.
- Across five years, Other financing activities topped out at $153.3 million in Q4 2024 and bottomed at -$210000.0 in Q3 2023.
- Historically, Other financing activities has averaged $27.8 million across 3 years, with a median of $508000.0 in 2024.
- Annual changes were most pronounced in 2024 — Other financing activities soared 33013.61% — and 2025, when it sank 99.46%.
- Alumis' Other financing activities stood at $463000.0 in 2023, then jumped by 33013.61% to $153.3 million in 2024, then tumbled by 99.46% to $829000.0 in 2025.
- Business Quant data shows ALMS's Other financing activities at $829000.0 in Q4 2025, $153.3 million in Q4 2024, and $39.5 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Alumis | 1.43 Bn | 924.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 829,000.00 |
| Sep 30, 2024 | 192.78 Mn |
| Jun 30, 2024 | 508,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | 212,000.00 |
| Sep 30, 2023 | 41,000.00 |